TY - JOUR
T1 - Mouse models of neurofibromatosis 1 and 2
AU - Gutmann, David H.
AU - Giovannini, Marco
N1 - Funding Information:
Abbreviations: ERM, ezrin-radixin-moesin; GAP, GTPase-activating protein; MPNST, malignant peripheral nerve sheath tumor; NF1, neurofibromatosis type 1; NF2, neurofibromatosis type 2; WHO, World Health Organization Address all correspondence to: Dr. David H. Gutmann, Department of Neurology, Washington University School of Medicine, Box 8111, 660 S. Euclid Avenue, St. Louis, MO 63110, USA. E - mail: [email protected] 1D. H. G. is supported by grants from the American Cancer Society and the National Institutes of Health. M. G. is supported by Grants from the US Army Medical Research and Materiel Command, Ligue Nationale Franc¸aise contre le Cancer, Association pour la Recherche sur le Cancer, and the Association Neurofibromatoses et Recklinghausen. Received 7 March 2002; Accepted 8 March 2002.
PY - 2002
Y1 - 2002
N2 - The neurofibromatoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatosis 1 (NF1) are prone to the development of astrocytomas and peripheral nerve sheath tumors whereas those affected with neurofibromatosis 2 (NF2) develop schwannomas and meningiomas. The development of traditional homozygous knockout mice has provided insights into the roles of the NF1 and NF2 genes during development and in differentiation, but has been less instructive regarding the contribution of NF1 and NF2 dysfunction to the pathogenesis of specific benign and malignant tumors. Recent progress employing novel mouse targeting strategies has begun to illuminate the roles of the NF1 and NF2 gene products in the molecular pathogenesis of NF-associated tumors.
AB - The neurofibromatoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatosis 1 (NF1) are prone to the development of astrocytomas and peripheral nerve sheath tumors whereas those affected with neurofibromatosis 2 (NF2) develop schwannomas and meningiomas. The development of traditional homozygous knockout mice has provided insights into the roles of the NF1 and NF2 genes during development and in differentiation, but has been less instructive regarding the contribution of NF1 and NF2 dysfunction to the pathogenesis of specific benign and malignant tumors. Recent progress employing novel mouse targeting strategies has begun to illuminate the roles of the NF1 and NF2 gene products in the molecular pathogenesis of NF-associated tumors.
KW - Actin cytoskeleton
KW - ERM proteins
KW - Neurofibromin
KW - RAS
KW - Tumor suppressor gene
UR - http://www.scopus.com/inward/record.url?scp=0036020214&partnerID=8YFLogxK
U2 - 10.1038/sj.neo.7900249
DO - 10.1038/sj.neo.7900249
M3 - Review article
C2 - 12082543
AN - SCOPUS:0036020214
SN - 1522-8002
VL - 4
SP - 279
EP - 290
JO - Neoplasia
JF - Neoplasia
IS - 4
ER -